I81

Portal vein thrombosis

Portal vein thrombosis (PVT) is a clinical condition characterized by the development of a blood clot within the portal venous system, which includes the main portal vein and its intrahepatic branches, and may extend into the splenic or superior mesenteric veins. The condition is categorized as either acute or chronic. In acute PVT, the sudden occlusion of the vein can lead to intestinal ischemia and infarction if the mesenteric veins are involved. Chronic PVT is typically defined by the presence of portal cavernoma, a compensatory network of collateral vessels that forms around the site of the original thrombus. PVT is highly prevalent in patients with liver cirrhosis (where stasis and reduced procoagulant factors occur) and in those with hepatobiliary malignancies. In non-cirrhotic patients, PVT is frequently driven by underlying myeloproliferative neoplasms or inherited thrombophilias. The hemodynamic consequences include increased portal pressure, which can result in life-threatening complications such as gastroesophageal variceal hemorrhage and hypersplenism.

Clinical Symptoms

  • Sudden and severe abdominal pain (acute phase)
  • Abdominal distension and bloating
  • Nausea and vomiting
  • Fever and chills (suggestive of pylephlebitis)
  • Hematemesis (vomiting blood from esophageal varices)
  • Melena (dark, tarry stools from upper GI bleeding)
  • Splenomegaly (enlarged spleen)
  • Ascites (fluid accumulation in the abdomen)
  • Dyspepsia and early satiety
  • Anorexia and weight loss
  • Jaundice (typically only if biliary compression by cavernoma occurs)

Common Causes

  • Liver cirrhosis (stasis and altered coagulation balance)
  • Hepatocellular carcinoma (HCC) causing direct invasion or extrinsic compression
  • Pancreatic adenocarcinoma
  • Myeloproliferative neoplasms (e.g., Polycythemia vera, Essential thrombocythemia)
  • Factor V Leiden mutation
  • Prothrombin G20210A gene mutation
  • Deficiencies in natural anticoagulants (Protein C, Protein S, or Antithrombin III)
  • Antiphospholipid syndrome
  • Intra-abdominal infections (e.g., pylephlebitis, appendicitis, diverticulitis, pancreatitis)
  • Abdominal surgery (especially splenectomy or liver transplantation)
  • Blunt or penetrating abdominal trauma
  • Paroxysmal nocturnal hemoglobinuria (PNH)
  • Oral contraceptive use or pregnancy-related hypercoagulability

Documentation & Coding Tips

Distinguish between acute and chronic presentations as it dictates clinical management and coding specificity.

Example: Patient presents with acute onset of severe abdominal pain and nausea. Imaging confirms acute portal vein thrombosis with total occlusion of the main portal vein branch. No evidence of cavernous transformation noted. History of cirrhosis is absent. This acute status is prioritized over chronic monitoring for risk adjustment and represents a high-severity event.

Billing Focus: Identify the acuity of the thrombus and document the presence or absence of portal hypertension.

Document the underlying etiology, specifically differentiating between cirrhotic and non-cirrhotic portal vein thrombosis.

Example: 65-year-old male with known Hepatitis C related cirrhosis presenting for follow-up. Ultrasound with Doppler shows chronic portal vein thrombosis with partial recanalization. Patient also has associated splenomegaly and esophageal varices. Documenting the underlying cirrhosis (K74.60) alongside I81 ensures complete diagnostic mapping.

Billing Focus: Link the thrombosis to the underlying liver disease or hypercoagulable state.

Explicitly mention the presence of cavernous transformation as it signifies a chronic process.

Example: Chronic portal vein thrombosis with extensive cavernous transformation of the portal vein. Collateral vessels are visualized in the porta hepatis. Patient is currently stable on anticoagulation. This documentation confirms the chronicity and supports long-term management codes.

Billing Focus: Use specific anatomical terminology like cavernous transformation to support the chronicity of I81.

Specify the extent of the thrombus, including involvement of the mesenteric or splenic veins.

Example: CT Abdomen reveals extensive portal vein thrombosis extending into the superior mesenteric vein (SMV). No signs of bowel ischemia at this time. Plan for systemic anticoagulation with LMWH. Identifying SMV involvement is critical for monitoring bowel viability and coding for multiple sites.

Billing Focus: Site specificity and the extent of the thrombus are required for high-complexity medical decision making.

Clearly document any associated complications such as portal hypertension or variceal bleeding.

Example: Patient with known chronic portal vein thrombosis now presents with hematemesis. Endoscopy shows bleeding esophageal varices. Portal vein thrombosis is the primary driver of the portal hypertension (K76.6). This combination represents a high-risk clinical scenario for billing and coding.

Billing Focus: Document the relationship between the vascular obstruction and secondary manifestations like varices.

Relevant CPT Codes

Related Diagnoses

Hierarchy